Ezt az oldalt automatikusan lefordították, és a fordítás pontossága nem garantált. Kérjük, olvassa el a angol verzió forrásszöveghez.

mHealth fizikai aktivitás intervenció fiatal ráktúlélők számára (AYA-PACT)

2026. november 17. frissítette: AHS Cancer Control Alberta

A rákpróba után fizikailag aktívvá váló serdülők és fiatal felnőttek

In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.

A tanulmány áttekintése

Állapot

Aktív, nem toborzó

Körülmények

Beavatkozás / kezelés

Részletes leírás

Background:

There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis.

Aim:

Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors.

Methods:

The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.

Tanulmány típusa

Beavatkozó

Beiratkozás (Tényleges)

287

Fázis

  • Nem alkalmazható

Kapcsolatok és helyek

Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.

Tanulmányi helyek

    • Alberta
      • Calgary, Alberta, Kanada, T2N5G2
        • Arthur J.E. Child Comprehensive Cancer Centre
      • Edmonton, Alberta, Kanada, T6G2H9
        • University of Alberta

Részvételi kritériumok

A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.

Jogosultsági kritériumok

Tanulmányozható életkorok

15 év (Gyermek, Felnőtt)

Egészséges önkénteseket fogad

Nem

Tanulmányozható nemek

Összes

Leírás

Inclusion Criteria:

  • Lives in Alberta
  • Diagnosed with invasive malignancy in Alberta
  • Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences
  • Have the ability to read, write and speak English
  • Have access to the Internet on at least a weekly basis
  • Have a mobile phone with a text messaging plan
  • Willing to be randomized to either arm.

Exclusion Criteria:

  • Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q)
  • Currently pregnant or planning to become pregnant within the next 6 months
  • Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis

Tanulási terv

Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.

Hogyan készül a tanulmány?

Tervezési részletek

  • Elsődleges cél: Támogató gondoskodás
  • Kiosztás: Véletlenszerűsített
  • Beavatkozó modell: Párhuzamos hozzárendelés
  • Maszkolás: Kettős

Fegyverek és beavatkozások

Résztvevő csoport / kar
Beavatkozás / kezelés
Kísérleti: mHealth Physical Activity Intervention

The intervention arm will receive a 12 month mobile health (mHealth) physical activity intervention with a goal of increasing their moderate-vigorous intensity physical activity levels by 90 minutes per week above baseline.

The intervention includes a physical activity prescription, a Polar activity tracker watch, access to a private AYA cancer survivor community through the Polar Flow community platform, mHealth nudges and surveys via text messaging, and regular phone or email contact from study staff.

Nincs beavatkozás: Control

Controls received "standard of care" from their medical team and were not provided with any physical activity guidance.

Mit mér a tanulmány?

Elsődleges eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Changes in weekly minutes of moderate-vigorous intensity physical activity
Időkeret: Baseline to 12 months

Measured by ActiGraph

Baseline to 12 months

Másodlagos eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Changes in weekly minutes of moderate-vigorous intensity physical activity
Időkeret: Baseline to 6 months and 24 months.

Measured by ActiGraph

Baseline to 6 months and 24 months.
Changes in weekly minutes of sleep
Időkeret: Baseline, 6 months, 12 months, 24 months

Measured by ActiGraph

Baseline, 6 months, 12 months, 24 months
Changes in weekly minutes of sedentary time
Időkeret: Baseline, 6 months,12 months, 24 months

Measured by ActiGraph

Baseline, 6 months,12 months, 24 months
Changes in moderate-vigorous physical activity using the self-administered Past Year Total Physical Activity Questionnaire (PYTPAQ).
Időkeret: Baseline, 12 months, 24 months.

Met-Hours per week and hours per week of moderate-vigorous physical activity

Baseline, 12 months, 24 months.
Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality Score
Időkeret: Baseline, 6 months,12 months

Global score range is 0 to 23 where higher scores indicate worse sleep quality

Baseline, 6 months,12 months
Changes in weight
Időkeret: Baseline, 6 months,12 months

Measured in kilograms

Baseline, 6 months,12 months
Changes in body mass index (BMI)
Időkeret: Baseline, 6 months,12 months

Measured by combining height (meters) and weight (kilograms) and reported in kg/m2

Baseline, 6 months,12 months
Changes in waist and hip circumference
Időkeret: Baseline, 6 months,12 months

Measured in centimeters

Baseline, 6 months,12 months
Changes in cardiorespiratory fitness
Időkeret: Baseline, 6 months,12 months

Measured by peak oxygen consumption in relative (ml/kg/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation

Baseline, 6 months,12 months
Changes in cardiorespiratory fitness
Időkeret: Baseline, 6 months,12 months

Measured by peak oxygen consumption in absolute (L/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation

Baseline, 6 months,12 months
Changes in grip strength
Időkeret: Baseline, 6 months,12 months

Measured in kilograms using a hand dynamometer

Baseline, 6 months,12 months
Changes in upper body muscular strength
Időkeret: Baseline, 6 months,12 months

Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM

Baseline, 6 months,12 months
Changes in upper body muscular endurance
Időkeret: Baseline, 6 months,12 months

Measured in kilograms using the maximum number of chest press repetitions completed at 50% of estimated 1-RM

Baseline, 6 months,12 months
Changes in lower body muscular strength
Időkeret: Baseline, 6 months,12 months

Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM

Baseline, 6 months,12 months
Changes in lower body muscular endurance
Időkeret: Baseline, 6 months,12 months

Measured in kilograms using the maximum number of leg press repetitions completed at 70% of estimated 1-RM

Baseline, 6 months,12 months
Changes in frailty
Időkeret: Baseline, 6 months,12 months

Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Mental Health Component subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better mental health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Physical Health Component subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better physical health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Physical Functioning subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Role-physical subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Bodily Pain subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate less pain

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) General Health subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Vitality subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher vitality

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Social Functioning subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Role-emotional subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 Mental Health subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better mental health

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscale
Időkeret: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Physical subscale
Időkeret: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Emotional subscale
Időkeret: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Cognitive subscale
Időkeret: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Cancer Worry subscale
Időkeret: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 72. Higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 16 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 36 where higher scores indicate poorer cognition

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscale
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 16 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F)
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 52 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Comprehensive Score for Financial Toxicity (COST)
Időkeret: Baseline, 6 months,12 months

Score range is from 0 to 44 where higher scores indicate better financial wellbeing

Baseline, 6 months,12 months
Changes in fear of cancer recurrence - short form (FCRI-SF)
Időkeret: Baseline, 6 months, 12 months

Score range is from 0 - 36 where higher scores indicate greater fear of recurrence severity.

Baseline, 6 months, 12 months
Changes in Sedentary Behaviour using a 7 day Sedentary Recall
Időkeret: Baseline, 6 months, 12 months.

Hours of sitting during the week and on weekends for the following categories: (1) traveling to work, (2) at work or school, (3) watching television, (4) using a computer, and (5) leisure time not including television.

Baseline, 6 months, 12 months.
Changes in environmental barriers that prevent or limit walking and cycling where a person lives or works - PANES Questionnaire
Időkeret: Baseline, 6 months, 12 months.

Score range is from 1 to 4 with higher values indicating greater environmental support for physical activity.

Baseline, 6 months, 12 months.
Changes in Exercise Self-Efficacy - Subscale (FITNET Questionnaire)
Időkeret: Baseline, 6 months, 12 months

Range of scores from 11 to 55 with higher scores indicated higher self-efficacy.

Baseline, 6 months, 12 months
Changes in Social Support from Family and Friends related to Exercise - Subscale (FITNET Questionnaire)
Időkeret: Baseline, 6 months, 12 months.

Range of scores from 10 to 50 with higher scores indicating more support.

Baseline, 6 months, 12 months.
Changes in Self-Monitoring related to setting exercise goals and planning exercise activities - Subscale (FITNET Questionnaire)
Időkeret: Baseline, 6 months, 12 months.

Range of scores from 12 to 60 with higher scores indicating more self-monitoring.

Baseline, 6 months, 12 months.

Együttműködők és nyomozók

Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.

Együttműködők

Nyomozók

  • Tanulmányi igazgató: Miranda Fidler-Benaoudia, PhD, Cancer Care Alberta
  • Kutatásvezető: Christine Friedenreich, PhD, Cancer Care Alberta

Tanulmányi rekorddátumok

Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.

Tanulmány főbb dátumok

Tanulmány kezdete (Tényleges)

2021. szeptember 27.

Elsődleges befejezés (Tényleges)

2026. július 16.

A tanulmány befejezése (Becsült)

2027. május 1.

Tanulmányi regisztráció dátumai

Először benyújtva

2021. február 9.

Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak

2021. február 19.

Első közzététel (Tényleges)

2021. február 21.

Tanulmányi rekordok frissítései

Utolsó frissítés közzétéve (Tényleges)

2026. november 20.

Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak

2026. november 17.

Utolsó ellenőrzés

2026. szeptember 1.

Több információ

A tanulmányhoz kapcsolódó kifejezések

Terv az egyéni résztvevői adatokhoz (IPD)

Tervezi megosztani az egyéni résztvevői adatokat (IPD)?

NEM

Gyógyszer- és eszközinformációk, tanulmányi dokumentumok

Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz

Nem

Egy amerikai FDA által szabályozott eszközterméket tanulmányoz

Nem

Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .

Iratkozz fel